<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo270055" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39866807</article-id><article-id pub-id-type="pmc">PMC11757024</article-id>
<article-id pub-id-type="doi">10.1002/deo2.70055</article-id><article-id pub-id-type="publisher-id">DEO270055</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Peroral endoscopic myotomy for complex achalasia and the POEM difficulty score: An update</article-title><alt-title alt-title-type="left-running-head">YEE <sc>et&#x000a0;al</sc>.</alt-title></title-group><contrib-group><contrib id="deo270055-cr-0001" contrib-type="author" corresp="yes"><name><surname>Ching Hui Yee</surname><given-names>Carmen</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0003-3031-8095</contrib-id><xref rid="deo270055-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>carmen.chinghuiyee@mail.mcgill.ca</email></address></contrib><contrib id="deo270055-cr-0002" contrib-type="author"><name><surname>Youssef</surname><given-names>Michael</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8463-6601</contrib-id><xref rid="deo270055-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="deo270055-cr-0003" contrib-type="author"><name><surname>Woo</surname><given-names>Matthew</given-names></name><xref rid="deo270055-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo270055-cr-0004" contrib-type="author"><name><surname>Bechara</surname><given-names>Robert</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4543-5580</contrib-id><xref rid="deo270055-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="deo270055-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Internal Medicine</named-content>
<institution>McGill University</institution>
<city>Montreal</city>
<named-content content-type="country-part">Quebec</named-content>
<country country="CA">Canada</country>
</aff><aff id="deo270055-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Internal Medicine</named-content>
<institution>University of Toronto</institution>
<city>Toronto</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><aff id="deo270055-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Division of Gastroenterology</named-content>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<institution>University of Calgary</institution>
<city>Calgary</city>
<named-content content-type="country-part">Alberta</named-content>
<country country="CA">Canada</country>
</aff><aff id="deo270055-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Division of Gastroenterology</named-content>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<institution>Queen's University</institution>
<city>Kingston</city>
<named-content content-type="country-part">Ontario</named-content>
<country country="CA">Canada</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Carmen Ching Hui Yee, 2015a Av Grey, H4A 3N3, Montreal, QC, Canada.<break/> Email: <email>carmen.chinghuiyee@mail.mcgill.ca</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="29">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e70055</elocation-id><history>
<date date-type="rev-recd"><day>13</day><month>12</month><year>2024</year></date>
<date date-type="received"><day>25</day><month>9</month><year>2024</year></date>
<date date-type="accepted"><day>23</day><month>12</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e70055.pdf"/><abstract><title>Abstract</title><sec id="deo270055-sec-0010"><title>Objectives</title><p>We present an update on the (peroral endoscopic myotomy (POEM) difficulty score [PDS] by introducing a novel knife with waterjet functionality.</p></sec><sec id="deo270055-sec-0020"><title>Methods</title><p>This is a retrospective review of patients who underwent POEM between May 2018 and July 2023 at the Kingston Health Sciences Center. Demographic and procedural variables were compared using descriptive and inferential statistics.</p></sec><sec id="deo270055-sec-0030"><title>Results</title><p>One hundred thirty&#x02010;nine consecutive POEMs were included in the study. Seventy&#x02010;four (56.7% male; aged 56.7&#x000a0;&#x000b1;&#x000a0;16.5 years) complex achalasia (CA) and 65 (55.4% female; aged 47.3&#x000a0;&#x000b1;&#x000a0;20.2 years) non&#x02010;CA POEM procedures were performed. PDS correlates moderately with procedural efficiency with a correlation coefficient of 0.595 (Spearman's <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). The mean efficiency for non&#x02010;CA was 3.3&#x000a0;&#x000b1;&#x000a0;1.2&#x000a0;min/cm compared to CA as follows: type III 3.3&#x000a0;&#x000b1;&#x000a0;1.3&#x000a0;min/cm; prior myotomy 5.3&#x000a0;&#x000b1;&#x000a0;2.3&#x000a0;min/cm; &#x02267;4 prior procedures 4.0&#x000a0;&#x000b1;&#x000a0;1.7&#x000a0;min/cm; sigmoid type 5.2&#x000a0;&#x000b1;&#x000a0;2.4&#x000a0;min/cm. The median PDS for non&#x02010;CA was 1 (1&#x02013;5). In comparison, the median PDS for CA is as follows: type III 3 (2&#x02013;4); prior myotomy 4 (3&#x02013;5); &#x02267;4 prior procedures 3 (1.25&#x02013;4); sigmoid type 3 (2&#x02013;4). PDS excluding the presence of spastic contractions correlated better with procedural velocity, with a correlation coefficient of 0.645 (Spearman's <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001).</p></sec><sec id="deo270055-sec-0040"><title>Conclusions</title><p>PDS continues to moderately correlate with procedural efficiency using the novel knife. The presence of spastic contractions correlated poorly with procedural efficiency. Thus, it may be omitted in further studies.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo270055-kwd-0001">achalasia</kwd><kwd id="deo270055-kwd-0002">endoscopy</kwd><kwd id="deo270055-kwd-0003">myotomy</kwd><kwd id="deo270055-kwd-0004">natural orifice endoscopic surgery</kwd><kwd id="deo270055-kwd-0005">peroral endoscopic myotomy</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="0"/><table-count count="4"/><page-count count="7"/><word-count count="4311"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo270055-sec-0050"><title>INTRODUCTION</title><p>Achalasia is a rare motility disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and loss of peristaltic contractions in the esophageal body.<xref rid="deo270055-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Clinical symptoms include dysphagia, regurgitation, chest pain, and weight loss.<xref rid="deo270055-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Traditional treatment modalities included botulinum toxin (botox) injections, pneumatic dilation (PD), or laparoscopic Heller myotomy (LHM). More recently, Peroral Endoscopic Myotomy (POEM) has emerged as a minimally invasive therapy with high efficacy, even among patients who failed prior endoscopic or surgical therapies.<xref rid="deo270055-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="deo270055-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="deo270055-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> However, POEM can be technically challenging in complex achalasia (CA) which includes type III achalasia, sigmoid type, prior myotomy, or multiple prior treatments.<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> These features are associated with prolonged procedural time, higher failure rates, and perioperative complications.<xref rid="deo270055-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>
</p><p>In 2018, Bechara et&#x000a0;al. developed a POEM Difficulty Score (PDS) to describe procedural difficulty based on procedure&#x02010;related factors including fibrosis, oozing, orientation, distension of submucosal tunnel, and spastic contractions during the procedure. (Table&#x000a0;<xref rid="deo270055-tbl-0001" ref-type="table">1</xref>)<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Using the traditional triangle tip (TT) knife, the PDS correlated well with procedural velocity and difficulty and may indirectly predict postoperative success and complications.<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> A limitation is the need to exchange the instrument for an injection needle to expand the submucosa with saline to facilitate dissection.<xref rid="deo270055-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> More recently, the TT&#x02010;jet (TTJ) knife with waterjet functionality integrates dissection with an injection to decrease instrument exchanges during POEM.<xref rid="deo270055-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Consequently, it was shown to decrease operative time and increase procedural efficiency, regardless of PDS score.<xref rid="deo270055-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>
</p><table-wrap position="float" id="deo270055-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Peroral endoscopic myotomy difficulty score fibrosis, oozing, orientation, distention of tunnel, and spastic contractions variables.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">FOODS variables</th><th align="left" rowspan="1" colspan="1">Scoring system</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Fibrosis</td><td align="left" rowspan="1" colspan="1">
<p>a. None to minimal</p>
<p>b. Moderate</p>
<p>c. Severe</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Oozing</td><td align="left" rowspan="1" colspan="1">
<p>a. None to minimal</p>
<p>b. Moderate</p>
<p>c. Diffuse</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Orientation</td><td align="left" rowspan="1" colspan="1">
<p>a. Easy</p>
<p>b. Fair</p>
<p>c. Difficult</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Distension of tunnel</td><td align="left" rowspan="1" colspan="1">
<p>a. Excellent</p>
<p>b. Adequate</p>
<p>c. Poor</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Spastic contractions</td><td align="left" rowspan="1" colspan="1">
<p>a. Seldom or none</p>
<p>b. Moderately frequent</p>
<p>c. Very frequent</p>
</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>In this case series, we aim to report on the clinical and procedural efficacy of using the TTJ knife in POEM for a larger series of patients with CA and non&#x02010;CA. Additionally, we explore and update the correlation between PDS and procedural variables to better describe procedural difficulty in CA.</p></sec><sec id="deo270055-sec-0060"><title>METHODS</title><sec id="deo270055-sec-0070"><title>Study design</title><sec id="deo270055-sec-0080"><title>PDS</title><p>The PDS describes procedural variables that impact the technical difficulty of performing POEM.<xref rid="deo270055-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref>, <xref rid="deo270055-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo270055-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref> This score consists of five variables: fibrosis, oozing, orientation, distention of tunnel, and spastic contractions.<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Each variable is weighted equally, and the values assigned ranged from 0 to 2. (Table&#x000a0;<xref rid="deo270055-tbl-0001" ref-type="table">1</xref>) Details regarding each variable and its scoring system have been previously described.<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p></sec><sec id="deo270055-sec-0090"><title>Fibrosis</title><p>It is graded as follows: 0, minimal to no fibrosis (submucosa appears as a blue transparent layer); 1, mild&#x02010;moderate fibrosis (submucosa appears as a white web&#x02010;like tissue); 2, severe fibrosis (submucosa appears as a white muscle&#x02010;like structure without a blue transparent layer).<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>, <xref rid="deo270055-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref>
</p></sec><sec id="deo270055-sec-0100"><title>Orientation</title><p>It is graded as follows: 0, easy (no difficulty with orientation, tunnel easily advanced perpendicular to the circular muscle without significant reorientation required); 1, fair (slightly challenging orientation; however, easily reoriented with repeated withdrawal and advancement of the scope); 2, difficult (despite repeated withdrawal and advancement, orientation remains challenging).<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p></sec><sec id="deo270055-sec-0110"><title>Oozing</title><p>It is graded as follows: 0, absent/minimal submucosal oozing (non&#x02010;pulsatile bleeding, easily identified and treated without subsequent impairment in delineation of tissue planes); 1, moderate oozing (non&#x02010;pulsatile bleeding identified and controlled, may have a transient impact on subsequent delineation of tissue planes); 2, diffuse oozing (dispersed oozing that is difficult to identify a clear source and results in impaired visibility/ability to delineate tissue planes).<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p></sec><sec id="deo270055-sec-0120"><title>Distension of tunnel</title><p>It is graded as follows: 0, excellent (minimal to intermittent requirement for insufflation to maintain optimal working space); 1, adequate (persistent insufflation required to maintain optimal working space); 2, poor (even with continuous insufflation, the optimal working space cannot be achieved).<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p></sec><sec id="deo270055-sec-0130"><title>Spastic contractions</title><p>This refers to the frequency of abnormal spastic contractions encountered during the procedure. These contractions are felt and seen by the operator and result in impaired visualization and maneuverability. It is graded as follows: 0, seldom or no spastic contractions; 1, spastic contractions every 6&#x02013;10 s; 2, spastic contractions occurring every 0&#x02013;5 s.<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref>
</p></sec></sec><sec id="deo270055-sec-0140"><title>Patient characteristics</title><p>Patients classified as CA have either type III achalasia, prior myotomy, four or more previous endoscopic treatments (only botox injection or PD 30&#x000a0;&#x000a0;mm or more were counted; multiple bougie and/or balloon dilations&#x000a0;&#x0003c;30&#x000a0;&#x000a0;mm or dilations for which details were unknown were not sufficient to be classified as CA), and sigmoid type.<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> The primary outcome examined was clinical success defined by an Eckardt score of 3 or less at a minimum of 3 months follow&#x02010;up with the use of TTJ knife. Secondary outcomes examined include the correlation of PDS with procedural velocity in the CA subtype, further stratification of features associated with CA, and the correlation of PDS with preprocedural patient characteristics and symptoms. Procedural velocity was defined as total procedure time (min) divided by total myotomy length (cm). Procedural velocity will be interchangeably used with the term procedural efficiency.</p><p>Clinical, procedural, and demographic data were collected prospectively and retrospectively analyzed. A total of 139 consecutive patients undergoing POEM at a single tertiary care center between May 2018 and July 2023 were included in this series. The sole operator for this study (Robert Bechara) had undergone a formal 1&#x02010;year fellowship at Showa University, Digestive Diseases Center, under tutelage from Haruhino Inoue, the pioneer of POEM.<xref rid="deo270055-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref> Diagnosis of achalasia was made by high&#x02010;resolution esophageal manometry using the Chicago classification 4.0.<xref rid="deo270055-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>
</p></sec><sec id="deo270055-sec-0150"><title>Data collection</title><p>Clinical data collected for this study included age, gender, body mass index, American Society of Anesthesiologists (ASA) score, types of symptoms, duration of symptoms in months, achalasia subtype, prior treatment for achalasia, pre&#x02010;procedural Eckardt scores and integrated relaxation pressures (IRP). Procedural data included the length of myotomy, number of clips used for closure, operative time, PDS, intra/post&#x02010;procedural complications, and length of hospital stay. Complications were classified according to the Clavien&#x02010;Dindo classification.<xref rid="deo270055-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Post POEM follow&#x02010;up data include Eckardt scores, number of months since the procedure, follow&#x02010;up upper endoscopy findings, 24&#x02010;h pH testing off proton&#x02010;pump inhibitor (PPI) therapy (ZAN&#x02010;BG&#x02010;44; Diversatek Healthcare), and manometry (HRiM2 12 Fr Probe; Diversatek Healthcare) for follow&#x02010;up IRP.</p><p>The pre&#x02010; and post&#x02010;POEM protocol used during this study remained unchanged from the prior.<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> There were no changes in the techniques used by the operator (Robert Bechara). There were no changes to the definition of the PDS from the previous study.<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> All cases in this cohort were completed using a TTJ knife.</p></sec><sec id="deo270055-sec-0160"><title>Data analysis</title><p>Demographics and procedural variables were analyzed with descriptive statistics (mean&#x000a0;&#x000b1;&#x000a0;standard deviation {SD}; median, interquartile range [IQR]) and the Mann&#x02010;Whitney U&#x02010;test. The Eckardt scores pre&#x02010; and post&#x02010;POEM were compared using the Wilcoxon signed&#x02010;rank test. Spearman's correlation (Significance defined as <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.05) was used to analyze the relationship between PDS and procedural velocity. The correlation between preprocedural variables, symptoms, and PDS was analyzed with Spearman's correlation and Kruskal Wallis H test (Significance defined as <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.05). All calculations were performed using SPSS v29.</p></sec></sec><sec id="deo270055-sec-0170"><title>RESULTS</title><p>One hundred thirty&#x02010;nine consecutive POEMs were performed, with seventy&#x02010;four being CA. Demographic characteristics of patients with CA and non&#x02010;CA are shown in Table&#x000a0;<xref rid="deo270055-tbl-0002" ref-type="table">2</xref>. Patients with CA had a significantly longer duration of symptoms (median 93 months, IQR 24&#x02013;145.5) compared to non&#x02010;CA (median 36 months, IQR 19.5&#x02013;96) (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.002). Patients with CA have higher mean body mass index (27 [SD 6.1] vs. 23.3 [SD 4.2]) (<italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001) and were slightly older than the non&#x02010;CA group (mean age 56.7 [SD 16.5] vs. 47.3 [SD 20.2]) (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.009). The ASA score was greater in CA (median 3, IQR 2&#x02013;3) compared to non&#x02010;CA (median 2, IQR 2&#x02013;3) (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.013). Pre&#x02010;Eckardt scores were not significantly different between the groups (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.076).</p><table-wrap position="float" id="deo270055-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Demographic characteristics of patients with complex achalasia and non&#x02010;complex achalasia.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Baseline characteristics</th><th align="left" rowspan="1" colspan="1">Complex</th><th align="left" rowspan="1" colspan="1">Non&#x02010;complex</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p&#x02010;</italic>value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Total patients (male:female)</td><td align="left" rowspan="1" colspan="1">74 (42:32)</td><td align="left" rowspan="1" colspan="1">65 (36:29)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Age (years) [mean, SD]</td><td align="left" rowspan="1" colspan="1">56.7&#x000a0;&#x000b1; 16.5</td><td align="left" rowspan="1" colspan="1">47.3&#x000a0;&#x000b1; 20.2</td><td align="left" rowspan="1" colspan="1">0.009</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI (kg/m2) [mean, SD]</td><td align="left" rowspan="1" colspan="1">27.0&#x000a0;&#x000b1; 6.1</td><td align="left" rowspan="1" colspan="1">23.3&#x000a0;&#x000b1; 4.2</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">ASA class (median, IQR)</td><td align="left" rowspan="1" colspan="1">3 (2&#x02013;3)</td><td align="left" rowspan="1" colspan="1">2 (2&#x02013;3)</td><td align="left" rowspan="1" colspan="1">0.013</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of symptoms in months (median, IQR)</td><td align="left" rowspan="1" colspan="1">93 (23&#x02013;145.5)</td><td align="left" rowspan="1" colspan="1">36 (19.5&#x02013;96)</td><td align="left" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" rowspan="1" colspan="1">Achalasia subtype (total)</td><td align="left" rowspan="1" colspan="1">74</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type I</td><td align="left" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type II</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type III</td><td align="left" rowspan="1" colspan="1">39</td><td align="left" rowspan="1" colspan="1">N/A</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Unclassified</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Sigmoid (total)</td><td align="left" rowspan="1" colspan="1">34</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">S1</td><td align="left" rowspan="1" colspan="1">28</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">S2</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">4 or more previous treatments (total)</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Median number of treatments (<italic toggle="yes">n</italic>, range)</td><td align="left" rowspan="1" colspan="1">0 (0&#x02013;20)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pneumatic dilation</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Bougie or dilation not specified</td><td align="left" rowspan="1" colspan="1">14</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Botulinum toxin injection</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Prior myotomy</td><td align="left" rowspan="1" colspan="1">15</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="deo270055-tbl2-note-0001"><p>IQR, interquartile range; BMI, body mass index defined as weight in kilograms (kg) divided by height (m<sup>2</sup>); ASA, American Society of Anesthesiologists.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Of those classified as CA, it was comprised of type III (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;39), sigmoid type (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;34), and 4 or more previous treatments (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;8). Many CA patients had prior treatments, notably PD (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;12), bougie or dilation (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;14), botox injection (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;16), or prior myotomy (<italic toggle="yes">n</italic>&#x000a0;=&#x000a0;15).</p><p>The preprocedural outcomes are available in Table&#x000a0;<xref rid="deo270055-tbl-0003" ref-type="table">3</xref>. Patients with CA have significantly greater PDS (median 3, IQR 2&#x02013;4) compared to non&#x02010;CA (median 1, IQR 1&#x02013;2; <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). This corresponds to a longer operative time (mean 52.1 min [SD 20.4] vs. 42.1 min [SD 14.9]; <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.003). The mean procedural velocity (min/cm myotomy) was significantly greater in CA (4.2 [SD 2.2] vs. 3.3 [SD 1.2]; <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.008).</p><table-wrap position="float" id="deo270055-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>Peroral endoscopic myotomy procedural outcomes.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Procedural results of patients undergoing POEM</th><th align="left" rowspan="1" colspan="1">Complex</th><th align="left" rowspan="1" colspan="1">Non&#x02010;complex</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="left" rowspan="1" colspan="1">74</td><td align="left" rowspan="1" colspan="1">65</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Myotomy length (cm) [mean, SD]</td><td align="left" rowspan="1" colspan="1">13.6&#x000a0;&#x000b1; 4.8</td><td align="left" rowspan="1" colspan="1">13.4&#x000a0;&#x000b1; 4.2</td><td align="left" rowspan="1" colspan="1">0.800</td></tr><tr><td align="left" rowspan="1" colspan="1">Esophageal myotomy length (cm) [mean, SD]</td><td align="left" rowspan="1" colspan="1">11.6&#x000a0;&#x000b1; 4.9</td><td align="left" rowspan="1" colspan="1">11.4&#x000a0;&#x000b1; 4.1</td><td align="left" rowspan="1" colspan="1">0.851</td></tr><tr><td align="left" rowspan="1" colspan="1">Gastric myotomy length (cm) [mean, SD]</td><td align="left" rowspan="1" colspan="1">1.9&#x000a0;&#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">1.9&#x000a0;&#x000b1; 0.4</td><td align="left" rowspan="1" colspan="1">0.851</td></tr><tr><td align="left" rowspan="1" colspan="1">Clip (number) [median, IQR]</td><td align="left" rowspan="1" colspan="1">4 (4&#x02013;5)</td><td align="left" rowspan="1" colspan="1">4 (4&#x02013;5)</td><td align="left" rowspan="1" colspan="1">0.264</td></tr><tr><td align="left" rowspan="1" colspan="1">Operative time (min) [mean, SD]</td><td align="left" rowspan="1" colspan="1">52.1&#x000a0;&#x000b1; 20.4</td><td align="left" rowspan="1" colspan="1">42.1&#x000a0;&#x000b1; 14.9</td><td align="left" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">PDS (median, IQR)</td><td align="left" rowspan="1" colspan="1">3 (2&#x02013;4)</td><td align="left" rowspan="1" colspan="1">1 (1&#x02013;2)</td><td align="left" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Fibrosis (median, IQR)</td><td align="left" rowspan="1" colspan="1">1 (0&#x02013;1)</td><td align="left" rowspan="1" colspan="1">0 (0&#x02013;1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Oozing (median, IQR)</td><td align="left" rowspan="1" colspan="1">0 (0&#x02013;0)</td><td align="left" rowspan="1" colspan="1">0 (0&#x02013;0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Ease of orientation (median, IQR)</td><td align="left" rowspan="1" colspan="1">1 (0&#x02013;1)</td><td align="left" rowspan="1" colspan="1">0 (0&#x02013;1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Distension of tunnel (median, IQR)</td><td align="left" rowspan="1" colspan="1">1 (1&#x02013;1)</td><td align="left" rowspan="1" colspan="1">1 (0&#x02013;1)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Presence of spastic contractions (median, IQR)</td><td align="left" rowspan="1" colspan="1">0 (0&#x02013;1)</td><td align="left" rowspan="1" colspan="1">0 (0&#x02013;0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Velocity (min/cm myotomy) [mean, SD]</td><td align="left" rowspan="1" colspan="1">4.2&#x000a0;&#x000b1; 2.2</td><td align="left" rowspan="1" colspan="1">3.3&#x000a0;&#x000b1; 1.2</td><td align="left" rowspan="1" colspan="1">0.008</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of stay (days) [median, IQR]</td><td align="left" rowspan="1" colspan="1">1 (1&#x02010;1)</td><td align="left" rowspan="1" colspan="1">1 (1&#x02010;1)</td><td align="left" rowspan="1" colspan="1">0.892</td></tr><tr><td align="left" rowspan="1" colspan="1">Major complications (Clavien&#x02010;Dindo grade IIIb&#x02010;V)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">1*</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="deo270055-tbl3-note-0001"><p>IQR, interquartile range; PDS, peroral endoscopic myotomy difficulty score; POEM, peroral endoscopic myotomy.</p></fn><fn id="deo270055-tbl3-note-0002"><p>*1 Clavien&#x02010;Dindo grade IIIb event &#x02013; mucosotomy requiring clip &#x000d7;3.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>There were no differences in the total myotomy length or length of stay between CA and non&#x02010;CA patients. The non&#x02010;CA cohort had a grade I and IIIb complication, respectively. There was a leak because of clips falling off 3 days post&#x02010;discharge, managed conservatively, and a mucosotomy requiring an additional three clips without any clinical consequences.</p><p>The PDS correlated moderately with procedural velocity with a correlation coefficient of 0.595 (Spearman's <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). The procedural velocity for non&#x02010;CA was 3.3&#x000a0;min/cm [SD 1.2]. In comparison, procedural velocity for CA was 4.2&#x000a0;min/cm (SD 2.2; all CA types), 3.3&#x000a0;min/cm (SD 1.3; type III), 5.3&#x000a0;min/cm (SD 2.3; prior myotomy), 4.0&#x000a0;min/cm (SD 1.7; &#x02265;4 prior procedures), and 5.2&#x000a0;min/cm (SD 2.4; sigmoid type). The procedural velocity of CA excluding type III achalasia was 4.9&#x000a0;min/cm (SD 2.4). A separate analysis of individual PDS factors demonstrated a poor correlation between the presence of spastic contractions and procedural velocity at 0.1 (Spearman's <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.906). Meanwhile, the correlation coefficient between fibrosis and efficiency was 0.520 (Spearman's <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001); Oozing and efficiency 0.323 (<italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001); Ease of orientation and efficiency 0.351 (<italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001); Distension of tunnel and efficiency 0.4 (<italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). PDS not including the presence of spastic contractions correlated better with the procedural velocity at 0.645 (Spearman's <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001).</p><p>The PDS correlated weakly with preprocedural variables; ASA (Spearman's 0.269, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.002); body mass index (Spearman's 0.256, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.002); sex (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.471); age (Spearman's 0.219, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.001); pre&#x02010;Eckardt score (Spearman's&#x000a0;=&#x000a0;0.094, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.271), and symptoms (dysphagia, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.198; regurgitation, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.252; chest pain, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.28; weight loss, <italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.447). The PDS correlated moderately with duration of symptoms (Spearman's 0.344, <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). We were unable to identify any demographic or clinical variables that strongly correlate with difficulty.</p><p>Table&#x000a0;<xref rid="deo270055-tbl-0004" ref-type="table">4</xref> describes the post&#x02010;POEM follow&#x02010;up period. The median follow&#x02010;up period was 27 months (IQR 17&#x02013;35) in CA and 21.5 months (IQR 11.25&#x02013;40.75) in non&#x02010;CA. There was a significant improvement in Eckardt scores post&#x02010;procedure with 97&#x02013;98% of patients with post&#x02010;POEM Eckardt scores of 3 or less.</p><table-wrap position="float" id="deo270055-tbl-0004" content-type="TABLE"><label>TABLE 4</label><caption><p>Post&#x02010;peroral endoscopic myotomy outcomes.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Follow up EGD</th><th align="left" rowspan="1" colspan="1">Complex</th><th align="left" rowspan="1" colspan="1">Non&#x02010;complex</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Total (<italic toggle="yes">n</italic>, %)</td><td align="left" rowspan="1" colspan="1">64 (86.5%)</td><td align="left" rowspan="1" colspan="1">52 (80%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Esophagitis (<italic toggle="yes">n</italic>, %)</td><td align="left" rowspan="1" colspan="1">26 (40.6%)</td><td align="left" rowspan="1" colspan="1">25 (48%)</td><td align="left" rowspan="1" colspan="1">0.671</td></tr><tr><td align="left" rowspan="1" colspan="1">LA A (<italic toggle="yes">n</italic>)</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">LA B (<italic toggle="yes">n</italic>)</td><td align="left" rowspan="1" colspan="1">13</td><td align="left" rowspan="1" colspan="1">16</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">LA C (<italic toggle="yes">n</italic>)</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Follow up 24&#x000a0;h pH study total (n, %)</td><td align="left" rowspan="1" colspan="1">19 (25.7%)</td><td align="left" rowspan="1" colspan="1">21 (32.3%)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Abnormal pH&#x000a0;&#x0003c;&#x000a0;4 (<italic toggle="yes">n</italic>)</td><td align="left" rowspan="1" colspan="1">12</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">0.071</td></tr></tbody></table><table-wrap-foot><fn id="deo270055-tbl4-note-0001"><p>EGD, esophagogastroduodenoscopy.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Follow&#x02010;up endoscopy was completed 3&#x02013;6 months post&#x02010;POEM in 64 (86.5%) CA and 52 (80%) non&#x02010;CA patients. Esophagitis was classified according to the LA classification.<xref rid="deo270055-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> Esophagitis was found in 26 (40.6%; LA A, seven patients; LA B, 13 patients; LA C, six patients) and 25 (48%; LA A, seven patients; LA B, 16 patients; LA C, two patients) CA and non&#x02010;CA patients, respectively. Abnormal pH exposure was defined as esophageal pH&#x000a0;&#x0003c;&#x000a0;4 greater than 4.2% of total time. This was seen in 63.1% and 47.6% of CA and non&#x02010;CA patients, respectively. Based on the Lyon 2.0 consensus, 29.7% and 34.6% of CA and non&#x02010;CA patients met the criteria for gastroesophageal reflux disease (GERD).<xref rid="deo270055-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</p></sec><sec id="deo270055-sec-0180"><title>DISCUSSION</title><p>In this case series, we present data further supporting the efficacy and safety of POEM for patients with both CA and non&#x02010;CA. Furthermore, we demonstrate improvement in procedural velocity, especially in CA with the introduction of the TTJ knife. In addition, we continue to show that PDS correlated with procedural efficiency using the TTJ knife.</p><sec id="deo270055-sec-0190"><title>TTJ knife in POEM</title><p>There is an increase in the mean procedural velocity between the current and previous cohorts (Tables <xref rid="deo270055-supinfo-0001" ref-type="">S1&#x02013;3</xref>). This can be explained using the new TTJ knife in this cohort. Compared to the conventional TT knife, the built&#x02010;in injection needle function reduces the mean number of instrument changes by 90%, and the usage of coagulation forceps for hemostasis by 59%.<xref rid="deo270055-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Tang et&#x000a0;al. reported that the conventional TT knife was associated with longer procedural times compared to a hybrid knife with similar functionality as the TTJ knife (<italic toggle="yes">p</italic>&#x000a0;=&#x000a0;0.014).<xref rid="deo270055-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>
</p><p>Additionally, there is a reduction in the mean operative time (min) between the current and previous study (Tables <xref rid="deo270055-supinfo-0001" ref-type="">S1&#x02013;3</xref>). This is despite a slight increase in the median PDS between the current and previous cohorts.<xref rid="deo270055-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> Although the comparison may be limited due to differences in sample size and improved operator expertise over the study's duration, we are reassured that the threshold for proficiency (up to 60 cases) was well surpassed by the primary operator prior to this cohort's initiation. This is further supported by the similar clinical outcomes observed in both groups and the number of procedures performed by the operator by the time the study was conducted. (Table <xref rid="deo270055-supinfo-0001" ref-type="">S4</xref>).<xref rid="deo270055-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>
</p></sec><sec id="deo270055-sec-0200"><title>PDS correlation</title><p>In this study, we demonstrated that PDS correlates with procedural efficiency with the TTJ knife. There appears to be a reduction in variability in the PDS and procedural efficiency between CA and non&#x02010;CA compared to the previous study (Tables <xref rid="deo270055-supinfo-0001" ref-type="">S5</xref> and <xref rid="deo270055-supinfo-0001" ref-type="">S6</xref>).<xref rid="deo270055-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> The correlation coefficient between PDS and procedural efficiency was 0.772 (Spearman's <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001) compared to the current value of 0.595 (Spearman's <italic toggle="yes">p</italic>&#x000a0;&#x0003c;&#x000a0;0.001). Of note, we observed a poor correlation between the presence of spastic contractions and procedural efficiency possibly due to the ability of the TTJ knife to perform repeated submucosal injections to keep the submucosa well&#x02010;lifted, minimizing any effect of spastic contractions.<xref rid="deo270055-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> As such, with an experienced operator and the use of the TTJ knife, type III achalasia can be reclassified as non&#x02010;CA, and spastic contractions may be omitted from the PDS.</p><p>We observed only a weak correlation between PDS and preprocedural variables (i.e., pre&#x02010;procedural Eckardt scores and symptomatology). This is a limitation of PDS due to the inability to use preprocedural variables to predict procedural difficulty pre&#x02010;operatively. Future research is needed to investigate other preprocedural variables that might correlate better with the PDS and be used to predict preoperative procedural difficulty.</p><p>In comparing the PDS with other scoring systems, Nakai et&#x000a0;al. published a risk&#x02010;scoring system identifying challenging POEMs.<xref rid="deo270055-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> The scoring system involved a point&#x02010;based system with preoperative factors such as duration of symptoms, antithrombotic use, Chicago classification, and grade 3 dilation. These preoperative factors were shown to correlate well with procedural difficulty and complication rates. Expert endoscopists can enhance patient selection for the POEM procedure by utilizing a combined scoring system, including risk assessment and PDS, to predict procedural difficulty and efficiency.<xref rid="deo270055-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="deo270055-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref>, <xref rid="deo270055-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> The PDS could be utilized to track trainee progress by monitoring how variability in procedural efficiency decreases as competency improves. For instance, trainees could be expected to achieve a target efficiency &#x02013; based on metrics established by the supervisor &#x02013; without complications for cases with a PDS of 0&#x02013;2 before progressing to more challenging cases. Additionally, it can serve as a quality assurance tool, allowing POEM operators to record and track outcomes across cases with varying PDS scores.</p></sec><sec id="deo270055-sec-0210"><title>CA and difficult POEMs</title><p>Tan et&#x000a0;al. defined difficult POEMs as POEM with (1) prolonged procedure time, (2) occurrence of major intraoperative adverse events, or (3) aborted procedures owing to the morphological or pathophysiologic changes of the esophagus. Certain characteristics such as sigmoid&#x02010;type, submucosal fibrosis, prior treatments, spastic type (type III achalasia, distal esophageal spasm, and hypercontractile esophagus), and achalasia with diverticulum or situs inversus are associated with difficult POEMs.<xref rid="deo270055-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>
</p><p>In our study, type III achalasia had a similar procedural velocity to non&#x02010;CA. We also found that spastic contractions correlated poorly with procedural velocity and the PDS. Hence, type III achalasia may not be associated with difficult POEMs.<xref rid="deo270055-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref>
</p><p>With respect to postoperative outcomes, both CA and non&#x02010;CA patients reported significant improvements in their Eckardt scores following POEM. Importantly, rates of esophagitis and GERD were also similar between the two groups. Previous studies have demonstrated higher rates of reflux esophagitis post&#x02010;POEM with alcohol use, obesity, and length of full&#x02010;thickness myotomy.<xref rid="deo270055-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> However, the type of achalasia and sigmoid esophagus were not statistically significant, and prior PD or laparoscopic Heller myotomy were in fact protective against GERD.<xref rid="deo270055-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> This suggests that GERD rates may not increase with factors typically associated with CA.</p></sec><sec id="deo270055-sec-0220"><title>Limitations and methodological considerations</title><p>A notable limitation is the study design. As a single&#x02010;center, single&#x02010;operator series, generalizability to other populations is limited. Other studies assessing POEM difficulty reported similar methodological limitations.<xref rid="deo270055-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref>, <xref rid="deo270055-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="deo270055-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> Despite a slightly larger number of patients in this series, the number of complications was insufficient to attempt an analysis to identify a correlation with PDS.</p></sec></sec><sec id="deo270055-sec-0230"><title>CONCLUSION</title><p>In this update to the PDS, it was found that the PDS continues to correlate well with procedural velocity in CA and non&#x02010;CA. However, with the introduction of the TT&#x02010;J knife, type III achalasia and spastic contractions no longer correlate strongly with procedural velocity or PDS and will be removed from the classification of CA. The PDS can be used to compare cases across different sites, assess POEM difficulty during procedures, and identify instances where novice trainees may benefit from expert intervention. Additionally, the PDS could serve as an adjunct for quality improvement and assurance by tracking outcomes for various types of CA and non&#x02010;CA cases across PDS scores. This approach can help identify outliers that indicate the need for quality initiatives or demonstrate that standards are being met for designation as an &#x0201c;expert POEM center&#x0201d;. Future research should involve a more diverse group of operators and patients from multiple centers to validate these findings further.</p></sec><sec sec-type="COI-statement" id="deo270055-sec-0240"><title>CONFLICT OF INTEREST STATEMENT</title><p>Robert Bechara: Consulting fees &#x02013; Vantage Endoscopy, Olympus, Pentax; Payment or honoraria for lectures given &#x02013; Pendopharm, Pentax, Olympus. All other authors declare no conflict of interest.</p></sec><sec id="deo270055-sec-0250"><title>ETHICS STATEMENT</title><p>Approval of the research protocol by an Institutional Reviewer Board: N/A</p></sec><sec id="deo270055-sec-0260"><title>PATIENT CONSENT STATEMENT</title><p>N/A</p></sec><sec id="deo270055-sec-0270"><title>CLINICAL TRIAL REGISTRATION</title><p>N/A</p></sec><sec id="deo270055-sec-0280"><title>ANIMAL STUDIES</title><p>N/A</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo270055-supinfo-0001" position="float" content-type="local-data"/><supplementary-material id="deo270055-supitem-0001" position="float" content-type="local-data"><caption><p>DENOP_Supplement_2024&#x02010;11&#x02010;25.docx.</p></caption><media xlink:href="DEO2-5-e70055-s001.docx"/></supplementary-material></sec></body><back><ref-list id="deo270055-bibl-0001"><title>REFERENCES</title><ref id="deo270055-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo270055-cit-0001">
<string-name>
<surname>Savarino</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Bhatia</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Roman</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Achalasia</article-title>. <source>Nat Rev Dis Primers</source>
<year>2022</year>; <volume>8</volume>: <issue>28</issue>.</mixed-citation></ref><ref id="deo270055-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo270055-cit-0002">
<string-name>
<surname>Ahmed</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Othman</surname>
<given-names>MO</given-names>
</string-name>. <article-title>Peroral endoscopic myotomy (POEM) for achalasia</article-title>. <source>J Thorac Dis</source>
<year>2019</year>; <volume>11</volume> (Suppl <issue>12</issue>): <fpage>S1618</fpage>&#x02013;<lpage>1628</lpage>.<pub-id pub-id-type="pmid">31489229</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo270055-cit-0003">
<string-name>
<surname>Sharata</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Kurian</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Dunst</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Bhayani</surname>
<given-names>NH</given-names>
</string-name>, <string-name>
<surname>Reavis</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Swanstrom</surname>
<given-names>LL</given-names>
</string-name>. <article-title>Peroral endoscopic myotomy (POEM) is safe and effective in the setting of prior endoscopic intervention</article-title>. <source>J Gastrointest Surg</source>
<year>2013</year>; <volume>17</volume>: <fpage>1188</fpage>&#x02013;<lpage>1192</lpage>.<pub-id pub-id-type="pmid">23609138</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo270055-cit-0004">
<string-name>
<surname>Ling</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Guo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zou</surname>
<given-names>X</given-names>
</string-name>. <article-title>Effect of peroral endoscopic myotomy in achalasia patients with failure of prior pneumatic dilation: A prospective case&#x02010;control study</article-title>. <source>J Gastroenterol Hepatol</source>
<year>2014</year>; <volume>29</volume>: <fpage>1609</fpage>&#x02013;<lpage>1613</lpage>.<pub-id pub-id-type="pmid">24628480</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo270055-cit-0005">
<string-name>
<surname>Orenstein</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Raigani</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Wu</surname>
<given-names>YV</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Peroral endoscopic myotomy (POEM) leads to similar results in patients with and without prior endoscopic or surgical therapy</article-title>. <source>Surg Endosc</source>
<year>2015</year>; <volume>29</volume>: <fpage>1064</fpage>&#x02013;<lpage>1070</lpage>.<pub-id pub-id-type="pmid">25249143</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo270055-cit-0006">
<string-name>
<surname>Bechara</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Woo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hookey</surname>
<given-names>L</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Peroral endoscopic myotomy (POEM) for complex achalasia and the POEM difficulty score</article-title>. <source>Dig Endosc</source>
<year>2019</year>; <volume>31</volume>: <fpage>148</fpage>&#x02013;<lpage>155</lpage>.<pub-id pub-id-type="pmid">30417948</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo270055-cit-0007">
<string-name>
<surname>Qu&#x000e9;n&#x000e9;herv&#x000e9;</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Vauquelin</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Berger</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Coron</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Olivier</surname>
<given-names>R</given-names>
</string-name>. <article-title>Risk factors for clinical failure of peroral endoscopic myotomy in achalasia</article-title>. <source>Front Med</source>
<year>2022</year>; <volume>8</volume>: <elocation-id>1099533</elocation-id>.</mixed-citation></ref><ref id="deo270055-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo270055-cit-0008">
<string-name>
<surname>Motomura</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hew</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bechara</surname>
<given-names>R</given-names>
</string-name>. <article-title>Novel triangle tip&#x02010;jet knife increases efficiency in peroral endoscopic myotomy for achalasia</article-title>. <source>JGH Open</source>
<year>2021</year>; <volume>5</volume>: <fpage>1142</fpage>&#x02013;<lpage>1147</lpage>.<pub-id pub-id-type="pmid">34621999</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo270055-cit-0009">
<string-name>
<surname>Lv</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>D</given-names>
</string-name>. <article-title>Peroral endoscopic full&#x02010;thickness myotomy for the treatment of sigmoid&#x02010;type achalasia: Outcomes with a minimum follow&#x02010;up of 12 months</article-title>. <source>Eur J Gastroenterol Hepatol</source>
<year>2016</year>; <volume>28</volume>: <fpage>30</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">26473299</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo270055-cit-0010">
<string-name>
<surname>Wu</surname>
<given-names>QN</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>XY</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>XC</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Submucosal fibrosis in achalasia patients is a rare cause of aborted peroral endoscopic myotomy procedures</article-title>. <source>Endoscopy</source>
<year>2017</year>; <volume>49</volume>: <fpage>736</fpage>&#x02013;<lpage>744</lpage>.<pub-id pub-id-type="pmid">28658680</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo270055-cit-0011">
<string-name>
<surname>Bechara</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Ikeda</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Inoue</surname>
<given-names>H</given-names>
</string-name>. <article-title>Peroral endoscopic myotomy: An evolving treatment for achalasia</article-title>. <source>Nat Rev Gastroenterol Hepatol</source>
<year>2015</year>; <volume>12</volume>: <fpage>410</fpage>&#x02013;<lpage>426</lpage>.<pub-id pub-id-type="pmid">26035678</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo270055-cit-0012">
<string-name>
<surname>Hayashi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nishiyama</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Predictors of incomplete resection and perforation associated with endoscopic submucosal dissection for colorectal tumors</article-title>. <source>Gastrointest Endosc</source>
<year>2014</year>; <volume>79</volume>: <fpage>427</fpage>&#x02013;<lpage>435</lpage>.<pub-id pub-id-type="pmid">24210654</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo270055-cit-0013">
<string-name>
<surname>Kim</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Nam</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Choi</surname>
<given-names>CW</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Risk factors associated with difficult gastric endoscopic submucosal dissection: Predicting difficult ESD</article-title>. <source>Surg Endosc</source>
<year>2017</year>; <volume>31</volume>: <fpage>1617</fpage>&#x02013;<lpage>1626</lpage>.<pub-id pub-id-type="pmid">27495343</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo270055-cit-0014">
<string-name>
<surname>Jeong</surname>
<given-names>JY</given-names>
</string-name>, <string-name>
<surname>Oh</surname>
<given-names>YH</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>YH</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Does submucosal fibrosis affect the results of endoscopic submucosal dissection of early gastric tumors?</article-title>
<source>Gastrointest Endosc</source>
<year>2012</year>; <volume>76</volume>: <fpage>59</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">22726467</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo270055-cit-0015">
<string-name>
<surname>Inoue</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Minami</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kobayashi</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Peroral endoscopic myotomy (POEM) for esophageal achalasia</article-title>. <source>Endoscopy</source>
<year>2010</year>; <volume>42</volume>: <fpage>265</fpage>&#x02013;<lpage>271</lpage>.<pub-id pub-id-type="pmid">20354937</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo270055-cit-0016">
<string-name>
<surname>Yadlapati</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kahrilas</surname>
<given-names>PJ</given-names>
</string-name>, <string-name>
<surname>Fox</surname>
<given-names>MR</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Esophageal motility disorders on high&#x02010;resolution manometry: Chicago classification version 4.0</article-title>. <source>Neurogastroenterol Motil</source>
<year>2021</year>; <volume>33</volume>: <elocation-id>e14058</elocation-id>.<pub-id pub-id-type="pmid">33373111</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo270055-cit-0017">
<string-name>
<surname>Dindo</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Demartines</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Clavien</surname>
<given-names>PA</given-names>
</string-name>. <article-title>Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey</article-title>. <source>Ann Surg</source>
<year>2004</year>; <volume>240</volume>: <fpage>205</fpage>&#x02013;<lpage>213</lpage>.<pub-id pub-id-type="pmid">15273542</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo270055-cit-0018">
<string-name>
<surname>Lundell</surname>
<given-names>LR</given-names>
</string-name>, <string-name>
<surname>Dent</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bennett</surname>
<given-names>JR</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Endoscopic assessment of oesophagitis: Clinical and functional correlates and further validation of the Los Angeles classification</article-title>. <source>Gut</source>
<year>1999</year>; <volume>45</volume>: <fpage>172</fpage>&#x02013;<lpage>180</lpage>.<pub-id pub-id-type="pmid">10403727</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo270055-cit-0019">
<string-name>
<surname>Gyawali</surname>
<given-names>CP</given-names>
</string-name>, <string-name>
<surname>Yadlapati</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Fass</surname>
<given-names>R</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Updates to the modern diagnosis of GERD: Lyon consensus 2.0</article-title>. <source>Gut</source>
<year>2024</year>; <volume>73</volume>: <fpage>361</fpage>&#x02013;<lpage>371</lpage>.<pub-id pub-id-type="pmid">37734911</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo270055-cit-0020">
<string-name>
<surname>Tang</surname>
<given-names>X</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wei</surname>
<given-names>Z</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Factors predicting the technical difficulty or peroral endoscopic myotomy for achalasia</article-title>. <source>Surg Endosc</source>
<year>2016</year>; <volume>30</volume>: <fpage>3774</fpage>&#x02013;<lpage>3782</lpage>.<pub-id pub-id-type="pmid">26659228</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="deo270055-cit-0021">
<string-name>
<surname>Cheng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Clymer</surname>
<given-names>JW</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>BP</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Prolonged operative duration is associated with complications: A systematic review and meta&#x02010;analysis</article-title>. <source>J Surg Res</source>
<year>2018</year>; <volume>229</volume>: <fpage>134</fpage>&#x02013;<lpage>144</lpage>.<pub-id pub-id-type="pmid">29936980</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo270055-cit-0022">
<string-name>
<surname>Puli</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>Wagh</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Forcione</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Gopakumar</surname>
<given-names>H</given-names>
</string-name>. <article-title>Learning curve for esophageal peroral endoscopic myotomy: A systematic review and meta&#x02010;analysis</article-title>. <source>Endosc</source>
<year>2023</year>; <volume>55</volume>: <fpage>355</fpage>&#x02013;<lpage>360</lpage>.</mixed-citation></ref><ref id="deo270055-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo270055-cit-0023">
<string-name>
<surname>Nabi</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Ramchandani</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Chavan</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kalapala</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Darisetty</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Reddy</surname>
<given-names>DN</given-names>
</string-name>. <article-title>Outcome of peroral endoscopic myotomy in achalasia cardia: Experience with a new triangular knife</article-title>. <source>Saudi J Gastroenterol</source>
<year>2018</year>; <volume>24</volume>: <fpage>18</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">29451180</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="deo270055-cit-0024">
<string-name>
<surname>Nakai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Abe</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Risk&#x02010;scoring system for predicting challenging cases of peroral endoscopic myotomy</article-title>. <source>Dig Endosc</source>
<year>2023</year>; <volume>35</volume>: <fpage>729</fpage>&#x02013;<lpage>735</lpage>.<pub-id pub-id-type="pmid">36571213</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="deo270055-cit-0025">
<string-name>
<surname>Kadiyala</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Canakis</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>DU</given-names>
</string-name>, <string-name>
<surname>Xue</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Fan</surname>
<given-names>GH</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>RE</given-names>
</string-name>. <article-title>Comparing clinical success and procedural difficulty between treatment&#x02010;na&#x000ef;ve and treatment&#x02010;refractory patients with esophageal motility disorders during peroral endoscopic myotomy</article-title>. <source>Gastrointest Endosc</source>
<year>2023</year>; <volume>98</volume>: <fpage>19</fpage>&#x02013;<lpage>27.e11</lpage>.<pub-id pub-id-type="pmid">36739994</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="deo270055-cit-0026">
<string-name>
<surname>Teitelbaum</surname>
<given-names>EN</given-names>
</string-name>, <string-name>
<surname>Soper</surname>
<given-names>NJ</given-names>
</string-name>, <string-name>
<surname>Arafat</surname>
<given-names>FO</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al</italic>. <article-title>Analysis of a learning curve and predictors of intraoperative difficulty for peroral esophageal myotomy (POEM)</article-title>. <source>J Gastrointest Surg</source>
<year>2014</year>; <volume>18</volume>: <fpage>92</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="pmid">24002767</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="deo270055-cit-0027">
<string-name>
<surname>Tan</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yan</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Long</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Huo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>D</given-names>
</string-name>. <article-title>Difficult peroral endoscopic myotomy: Definition and management strategies</article-title>. <source>Expert Rev Gastroenterol Hepatol</source>
<year>2019</year>; <volume>13</volume>: <fpage>933</fpage>&#x02013;<lpage>942</lpage>.<pub-id pub-id-type="pmid">31566998</pub-id>
</mixed-citation></ref><ref id="deo270055-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="deo270055-cit-0028">
<string-name>
<surname>Wessels</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Masclee</surname>
<given-names>GMC</given-names>
</string-name>, <string-name>
<surname>Baastiaansen</surname>
<given-names>BAJ</given-names>
</string-name>, <string-name>
<surname>Fockens</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Bredenoord</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>Incidence and risk factors of reflux esophagitis after peroral endoscopic myotomy</article-title>. <source>Neurogastroenterol Motil</source>
<year>2024</year>; <volume>36</volume>: <elocation-id>e14794</elocation-id>.<pub-id pub-id-type="pmid">38587128</pub-id>
</mixed-citation></ref></ref-list></back></article>